Ulker Biskuvi Sanayi AS (ULKER) Fair Value & Analysis
Consumer Defensive · TR · Market cap 31.9B TRY
Fair value as of: Aug 13, 2026
From 26 valuation models · updated 6 days ago
Share price +0.2% over the past month.
Below-average quality, screening 184% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (166.74 TRY). The market is more pessimistic than our downside scenario.
- A fairly wide model range (166.74 TRY to 346.51 TRY) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 12.37 TRY – 164.85 TRY · fair‑value band 166.74 TRY – 346.51 TRY · the 97.75 TRY price screens below the 277.20 TRY fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Ulker Biskuvi Sanayi AS (ULKER) currently trades at 97.75 TRY, while our model-based Fair Value estimate is 277.20 TRY, implying the stock looks roughly 183.6% undervalued today. The Quality Score stands at 42/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Ulker Biskuvi Sanayi AS generated revenue of 111B TRY at a net margin of 3.0%. Revenue grew 18.6% year over year. It earns a return on equity of 8.1%. Net debt stands at 34.0B TRY. Fundamentals as of Aug 13, 2026
Our scenario range runs from 166.74 TRY (bear case) to 346.51 TRY (bull case); at 97.75 TRY, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 27% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -37% fair-value upside, at 184%, ULKER screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (563.42 TRY) versus Asset-Based (78.57 TRY). Highest evidence: Growth DCF (80).
Notify me when ULKER reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 38
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Ülker Bisküvi Sanayi A.S., together with its subsidiaries, manufactures, markets, and sells biscuits, chocolates, chocolate coated biscuits, wafers, and cakes in Turkey and internationally. The company also offers spread chocolate, crackers, Bebe biscuits, light snacks, gum, gift chocolates and candies, kid's snacks, and food supplements.
Full company description
Ülker Bisküvi Sanayi A.S., together with its subsidiaries, manufactures, markets, and sells biscuits, chocolates, chocolate coated biscuits, wafers, and cakes in Turkey and internationally. The company also offers spread chocolate, crackers, Bebe biscuits, light snacks, gum, gift chocolates and candies, kid's snacks, and food supplements. It is also involved in trading and investment services. The company was founded in 1944 and is headquartered in Istanbul, Turkey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ulker Biskuvi Sanayi AS reported revenue of 112B TRY in FY2025 versus 12.5B TRY in FY2021, a compound +72.8%/yr. Reported net income was 4.9B TRY in FY2025.
Watch ULKER: get an alert when its fair value changes →
Peer Group
Confectioners · 80 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Confectioners median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Confectioners stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Chocoladefabriken Lindt & Sprüngli AG LISN | CHF 94,500 | CHF 9,669 | -90% |
| Mondelez International, Inc MDLZ | $62.66 | $27.36 | -56% |
| The Hershey Company HSY | $184.23 | $91.25 | -50% |
| Barry Callebaut AG BARN | CHF 1,136 | CHF 711.91 | -37% |
| ORION Corp 271560 | 132,800 KRW | 203,315 KRW | +53% |
| Guangxi Yuegui Guangye Holdings 000833 | ¥20.48 | ¥9.09 | -56% |
| Cloetta AB CLAB | kr 54.85 | kr 59.12 | +8% |
| Balrampur Chini Mills Limited BALRAMCHIN | ₹652.15 | ₹318.59 | -51% |
| PT Yupi Indo Jelly Gum Tbk YUPI | 1,295 IDR | 1,140 IDR | -12% |
| ORION Holdings 001800 | 26,850 KRW | 42,237 KRW | +57% |
Compare Ulker Biskuvi Sanayi AS with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Ulker Biskuvi Sanayi AS (ULKER) overvalued or undervalued?
What is the fair value of ULKER?
What is the quality score of ULKER?
What is the revenue of Ulker Biskuvi Sanayi AS (ULKER)?
What is the net profit margin of ULKER?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Ulker Biskuvi Sanayi AS and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.